MedTech Actuator
Matthew Frith is an experienced executive with a strong background in innovation, commercialization, and strategic management. Currently serving as Chief Operating Officer and Chief Commercial Officer at MedTech Actuator since April 2022, Matthew focuses on long-term growth strategies and supports startup founders while managing relationships within public policy and health ecosystems. As the Founder and Non-Executive Director of kin8 since April 2015, Matthew leads initiatives to translate innovation goals into impactful results for clients globally. Previous roles include Professor (Practice) at Monash University, Marketing Manager for ANZ at HPM Legrand Australia, and National Sales Manager at Gaf Control, among others. Matthew holds an MBA (Executive) from RMIT University.
This person is not in any teams
MedTech Actuator
Asia Pacific’s MedTech catalyst We set a new global standard for medical technology commercialisation acceleration. Our program deploys a dynamic, integrated program that supports rapid transformation of new ideas into solutions that change the face of global healthcare. MedTech startups accelerate from Seed stage to Series A in 15 months by combining talented creativity with disruptive financial models and comprehensive domain expertise, and by supporting leadership development to create the next generation of advanced technology entrepreneurs. Milestone momentum is rewarded with multiple capital injection points and the program is tightly linked to startup pathways across the globe. Driven by industry leadership, investor connectivity and market pull mechanisms, the MedTech Actuator is in the business of signal not noise: focusing on what really matters to transform healthcare and the future of innovation. The MedTech Actuator is also home to MedTech Actuator Origin - https://medtechactuator.com/origin.